133 related articles for article (PubMed ID: 32942146)
1. Immune cells in normal pregnancy and gestational trophoblastic diseases.
Tsonis O; Karpathiou G; Tsonis K; Paschopoulos M; Papoudou-Bai A; Kanavaros P
Placenta; 2020 Nov; 101():90-96. PubMed ID: 32942146
[TBL] [Abstract][Full Text] [Related]
2. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
[TBL] [Abstract][Full Text] [Related]
3. IgG expression in trophoblasts derived from placenta and gestational trophoblastic disease and its role in regulating invasion.
Yang M; Ha C; Liu D; Xu Y; Ma Y; Liu Y; Nian Y
Immunol Res; 2014 Oct; 60(1):91-104. PubMed ID: 24469916
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.
Bolze PA; Patrier S; Massardier J; Hajri T; Abbas F; Schott AM; Allias F; Devouassoux-Shisheboran M; Freyer G; Golfier F; You B
Int J Gynecol Cancer; 2017 Mar; 27(3):554-561. PubMed ID: 28060141
[TBL] [Abstract][Full Text] [Related]
5. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms.
Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W
Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420
[TBL] [Abstract][Full Text] [Related]
7. Human placental growth hormone: a potential new biomarker in gestational trophoblastic disease.
Hübener C; Bidlingmaier M; Wu Z; Diebold J; Delius M; Friese K; Strasburger CJ; Hasbargen U
Gynecol Oncol; 2015 Feb; 136(2):264-8. PubMed ID: 25448485
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of gestational trophoblastic diseases.
Shih IeM; Kurman RJ
Curr Mol Med; 2002 Feb; 2(1):1-12. PubMed ID: 11898845
[TBL] [Abstract][Full Text] [Related]
9. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
10. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
11. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases.
Lee SY; Lee HS; Gil M; Kim CJ; Lee YH; Kim KR; Park CS
Arch Pathol Lab Med; 2014 May; 138(5):643-50. PubMed ID: 24786121
[TBL] [Abstract][Full Text] [Related]
12. Pathology of gestational trophoblastic diseases.
Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and aetiology of gestational trophoblastic diseases.
Altieri A; Franceschi S; Ferlay J; Smith J; La Vecchia C
Lancet Oncol; 2003 Nov; 4(11):670-8. PubMed ID: 14602247
[TBL] [Abstract][Full Text] [Related]
14. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
16. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
17. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases.
Marzioni D; Quaranta A; Lorenzi T; Morroni M; Crescimanno C; De Nictolis M; Toti P; Muzzonigro G; Baldi A; De Luca A; Castellucci M
Histol Histopathol; 2009 Oct; 24(10):1213-22. PubMed ID: 19688690
[TBL] [Abstract][Full Text] [Related]
19. Genetics and molecular markers in gestational trophoblastic disease with special reference to their clinical application.
Matsuda T; Wake N
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):827-36. PubMed ID: 14614883
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 20 as a biomarker of gestational trophoblastic disease: diagnostic and prognostic significance.
Stackievicz R; Drucker L; Zemer R; Klein A; Markovitch O; Yarkoni S
Gynecol Oncol; 2002 Oct; 87(1):34-8. PubMed ID: 12468339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]